Pharmaceutical Supply – Naproxen Tablets

The contract outlines the supply and delivery of FDA-approved Naproxen Tablets, identified by NSN 6505011868758, to a U.S. Navy vessel under a subcontract issued by the Defense Logistics Agency under the Department of Defense. The pharmaceutical product must meet all FDA approval standards and be packaged in compliance with commercial labeling requirements, DLA Unit-of-Issue specifications, and military delivery protocols to ensure seamless integration into naval medical inventories. The tablets are to be furnished in bottle form, with packaging and labeling adhering strictly to federal and defense logistics standards to maintain traceability, sterility, and regulatory compliance throughout the supply chain. The contract, classified under NAICS code 325412 for Pharmaceutical Preparation Manufacturing, is set to be performed under a subcontract arrangement with a projected posting date of July 15, 2026. While specific delivery locations and point of contact details are not provided, the place of performance is intended to support naval operations, indicating a logistics focus on maritime deployment readiness. The contract references a specific DLA award and delivery identifier, confirming its formal status within the Department of Defense procurement system and underscoring the critical nature of ensuring uninterrupted access to essential analgesic medication for deployed personnel.